|
Jul 29
|
Amneal Pharmaceuticals (AMRX) Earnings Expected to Grow: Should You Buy?
|
|
Jul 29
|
Wall Street Analysts Think Amneal (AMRX) Could Surge 43.82%: Read This Before Placing a Bet
|
|
Jul 29
|
Q1 Earnings Highs And Lows: Amneal (NASDAQ:AMRX) Vs The Rest Of The Generic Pharmaceuticals Stocks
|
|
Jul 28
|
Is Amneal Pharmaceuticals (AMRX) Outperforming Other Medical Stocks This Year?
|
|
Jul 28
|
2 Reasons to Avoid AMRX and 1 Stock to Buy Instead
|
|
Jul 21
|
Amneal Announces Proposed Refinancing of Existing Credit Agreement, including Private Offering of Senior Secured Notes Due 2032
|
|
Jul 21
|
Amneal Reports Certain Preliminary Second Quarter 2025 Financial Results
|
|
Jul 18
|
Knight Therapeutics Announces Filing of New Drug Submission for CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Canada
|
|
Jul 12
|
Amneal Pharmaceuticals (AMRX) Announces FDA Approval of Prednisolone Acetate Ophthalmic Suspension
|
|
Jun 30
|
Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year?
|
|
Jun 26
|
5 Revealing Analyst Questions From Amneal’s Q1 Earnings Call
|
|
Jun 25
|
Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences
|
|
Jun 12
|
Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension
|
|
Apr 17
|
Even though Amneal Pharmaceuticals (NASDAQ:AMRX) has lost US$78m market cap in last 7 days, shareholders are still up 125% over 5 years
|
|
Apr 11
|
Amneal Donates $1.5 Million to Support Patients During Parkinson’s Awareness Month
|
|
Apr 8
|
Amneal to Report First Quarter 2025 Results on May 2, 2025
|
|
Apr 7
|
Amneal Announces New Data from Phase 3 Study Showing Significant Improvements in Sleep Quality with CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Parkinson’s Disease
|
|
Jan 23
|
Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin
|
|
Oct 1
|
Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases
|
|
Jul 29
|
Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags
|